UKRI Unveils New Research Data Policy to Streamline Publicly Funded Science
UKRI has launched a new research data policy to streamline data management for publicly funded science from April 2027.
Funding rounds, strategy and policy decisions shaping life sciences research in the UK.
NICE Advises a Single Saliva Test Could Speed Endometriosis Diagnosis in Primary Care
NICE recommends a saliva test that could speed up endometriosis diagnosis in UK primary care, according to The BMJ.
MRC backs new wave of research into fatal genetic diseases
MRC has announced new funding for research into fatal genetic diseases in its latest UK health update.
NICE Backs Weekly Insulin Jab as NHS Faces Major Diabetes Care Shift
NICE has approved a weekly insulin jab for type 2 diabetes, signalling a major shift in NHS treatment options.
MRC backs new genetic disease research as UK life sciences pipeline adds fresh momentum
MRC funding and recent August 2026 studies show strong momentum in UK life sciences, from rare diseases to vaccines and early diagnosis.
UK MRC Launches New Funding Round to Back Biomedical Research and New Treatments
UK MRC opens new funding rounds for obesity, precision prevention and biomedical research across the UK.
UK invests £50 million to accelerate mitochondrial disease research
UK invests £50 million in mitochondrial disease research to speed new therapies and improve outcomes for patients.
NICE Opens Consultation on New Draft PMOS Guideline to Speed Diagnosis and Follow-Up
NICE has opened consultation on a draft PMOS guideline focused on earlier diagnosis and annual review for NHS patients.
NICE Recommends Annual Reviews for New PMOS Guideline as UK Diagnosis Could Improve
NICE proposes annual PMOS reviews and earlier diagnosis in new draft guidance now open for public consultation.
NICE Recommends New NHS Option for Recurrent or Metastatic Cervical Cancer
NICE has recommended a new NHS treatment option for recurrent or metastatic cervical cancer, announced on 24 June 2026.
